Ologen (OculusGen)-Glaucoma MMC Control Trial in India
Status:
Unknown status
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of the ologen
(OculusGen) Biodegradable Collagen Matrix Implant and the MMC group in filtration surgery.